An observational study in Lead Poisoning, sponsored by Magellan Diagnostics. Status unknown at 3 sites in United States. Per ClinicalTrials.gov, last updated 2017-08-22.
Sponsored by Magellan Diagnostics · Observational
This study is to supplement our internal data that demonstrates the continued performance of capillary blood samples on Magellan's lead testing systems: LeadCare II, LeadCare Ultra (which have been cleared previously by FDA), and PediaStat, which is an upgraded LeadCare II instrument in development.
adults and children up to 18 years of age who are at risk of lead exposure, pregnant women who are at risk of lead exposure,
Exclusion Criteria:
Patients aged 18+ years
Device: Lead testing
Patients aged 7 - 17 years
Device: Lead testing
Patients aged under 7 years
Device: Lead testing
Fingerstick
Lead poisoning
\>10ug/dL lead in whole blood is considered lead poisoning These measurements will be taken to compare the fingerstick data collected in the field with data received through reference method
Time frame: 1 day
Documents are hosted by the registry — open the source record to download them.
This study is status unknown, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.